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ANALYSES OF CHLAMYDIA TRACHOMATIS L2 IN THE 
BACKGROUND OF THE HOST CELL PROTEOME – INCLUSION 
MEMBRANE PROTEINS. 
Svend Birkelund1, Lau Sennels1, Gunna Christiansen2 and Allan Stensballe1. 
1Department of Health Science and Technology, Aalborg University, Denmark 
2Department of Biomedicine, Aarhus University, Denmark 
 
Introduction 
The Chlamydia trachomatis elementary body (EB) proteome has been 
characterized with 2D-gel electrophoresis and identification of proteins 
with tryptic digest and subsequent protein identification by mass-
spectrometry (MS)(Shaw et al. 2002). The number of proteins that can be 
identified has increased after digesting complex protein samples and 
thereafter separating the peptides by liquid chromatography (LC) coupled 
MS/MS. The technique is called gel-free proteomics in contrary to 2D-gel 
based proteomics. Using this technique Skipp et al. (2005) identified 328 
proteins in purified EB of the 889 encoded in the genome (Thomson et al. 
2008). The technique has also been used to characterize the outer 
membrane complex of C. trachomatis L2 and to find in vivo cleavage sites 
of the proteins, especially between the auto-transporter and passenger 
domain of the polymorphic outer membrane proteins (Pmp), (Birkelund et 
al. 2009). Saka et al. (2011) identified 485 proteins in purified EB and 
reticulate bodies (RB). Due to the high quality of the data it was possible 
for them to quantify 373 of the proteins.  Fifty-nine proteins were only 
found in RB, and in EB the in vivo cleavages of the Pmp proteins could 
confirm the results of by Birkelund et al. (2009). Saka et al. identified 13 
Inclusion membrane proteins (Inc) in purified RBs and EBs. Due to the 
type III secretion of Inc to the inclusion membrane we expected to find 
additional Inc proteins by analyzing the entire infected host cell. 
By combining ultra high pressure LC (UHPLC) and a mass-spectrometer 
with a dynamic range of 105 and sub-ppm mass-accuracy, it is now 
possible to identify 7,093 proteins in a HeLa cell sample using MS/MS 
:LĞQLHZVNL et al. 2009). Therefore, we decided to characterize expression 
in C. trachomatis L2 infected host cells (HeLa) after 43 hrs of infection.  
 
Methods 
Semiconfluent monolayers of HeLa cells (75 cm2) were infected with C. trachomatis L2 
(434/Bu), for 30 minutes with the infectious dose of 1 IFU/cell and then incubated for 42 
hrs and 30 minutes in RPMI-1640 medium containing 10% FCS and gentamicin. Medium 
was also changed on un-infected HeLa cells. Cells were washed 3 times in PBS, and the 
cells were solubilized in 5% sodium deoxycholate (SDC), 50 mM triethylammonium 
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bicarbonate (TEAB) and phosphatase inhibitors. The samples were heated to 90°C for 5 
minutes. Filter-aided sample preparation (FASP) and digestion with trypsin was 
performed according to León et al. (2013) using 10 kDa spinfilters for buffer exchange. 
The samples were reduced with 12 mM Tris(2-carboxyethyl)phosphine hydrochloride, 
alkylated with 40 mM iodoacetamide and digested with trypsin (1:50). All reactions were 
done in 0.5% SDC and 50 mM TEAB. After digestion, formic acid was added to 0.5% and 
SDC was removed with ethyl acetate extraction.  
Samples were analyzed on a Thermo Electron QExactive mass spectrometer.  
 
RESULTS 
The trypsin-digested samples were separated with a UPLC system. The 
system was online coupled to a QExactive mass spectrometer. A 4-hrs 
UPLC (8-30%) gradient was used. The 12 highest intensity peptides were 
selected per second to high-energy collision dissociation (HCD) and MS2 
spectra were obtained. Spectra were extracted from raw files with Thermo 
Proteome Discoverer and searched with a Mascot server for C. trachomatis 
L2 peptides using all CHLT2 UnProtKB sequences.  
 
    Fig. 1) MS2 spectrum of a peptide ion form CTL0882 
 
In figure 1 the MS2 spectrum of a fragmented peptide ion of 2350.20 Da is 
seen. The mass difference between the peaks is analyzed for amino acid 
residues masses. Since the peptide is ionized in the C-terminal part, the 
sequence of the peptide is TTVSETQQQQLSTIETTLGSAK. The 
peptide is from the Inc protein CTL0882 (Ct618 homolog in D). 
The samples were run in triplicates resulting in approximately 900.000 
MS2 spectra for infected HeLa cells as well as for uninfected cells. 250 C. 
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trachomatis proteins were identified with more than 2 peptides with an 
expectancy score of  <e-4 and a mowse score of  >200 in the mascot search 
program. Accession numbers for predicted Inc proteins according to Lutter 
et al. (2012) were searched in the output. Seven predicted Inc proteins were 
identified with at least 2 different unique peptides (Table 1).  
 
Table 1     
Accession 
Number 
D 
homolog 
Peptide sequence Saka Inc 
CTL0371 
INCE_CHLT2 
CT116 LDNLTDPVR, SSPANEPAVQFF 0 E 
CTL0373 
B0B9M6_CHLT2  
 
CT118 VLSSVQSMPVIDK, 
SIGDSVSGAFDDINK, 
SIGDSVSGAFDDINKDNSR 
RB G 
CTL0402 
B0B9Q5_CHLT2 
CT147 SSDATVGLQHQIR, 
DLIDVVEESIETAK, 
DLIDTILQMGSAAGGVTPLVDGVHK 
RB/NQ  
CTL0466 
B0B9W4_CHLT2 
CT214 FAAPFLSLIEK, 
GASIPLISGQADDSLPNR 
EB  
CTL0476 
B0B9X4_CHLT2 
CT223 AHLDVCLGEK, EEISQLEQQLAK, 
VEANNGINDLSPAPEAK 
RB/NQ  
CTL0480 
B0B7K4_CHLT2 
CT288 QYDILNAAFNK, 
QLSQIDLTIQAPEK 
YDSINHSIEEISDR 
RB  
CTL0882 
B0B8J3_CHLT2 
CT618 LLSSATATTLR, 
TNPDGSFHLDLVSQQR, 
LSSVNDLFDLISSSCTLAR, 
TTVSETQQQQLSTIETTLGSAK 
RB  
 
Six of the proteins were also identified in purified RB/EB by Saka et al. 
(2011). IncE was not found in that study. To control the specificity of our 
C. trachomatis identifications, against the human protein background, we 
performed a database search of the MS data on the un-infected HeLa in a 
Mascot search against the L2 database.  Only chlamydia Glyceraldehyde-3-
phosphate dehydrogenase and PolyA polymerase were unambigously 
identified in the L2 database with high scores, due to the conserved 
peptides between the human and chlamydia proteins.  
 
DISCUSSION 
On unfractionated infected HeLa was it possible to identify 250 C. 
trachomatis L2 proteins with high confidence with the FASP method in 
combination with UHPLC and on-line MS.  Saka et al. (2011) identified 
426 proteins in purified EB and 269 in RB. However, the current method 
also gives the possibility to look at the changes in the host cell proteins and 
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the chlamydial proteins secreted to the host. Saka et al. (2011) found, 
however, many Inc proteins in their proteomics study of RB and EB even 
though the proteins should be secreted from the chlamydiae. This is likely 
due to presence of the Inc family proteins in chlamydiae before secretion. 
We found IncE (CT116) in additional to the Inc protein found bye Saka et 
al. 
The expression of IncE is in god agreement with Lutter et al. (2012) and 
Almeida et al. (2012) who showed that the incE gene in the LGV serovars 
had been under a positive selection pressure with many nonsynonymous 
nucleotide substitutions.  This was also the case for CT118 and CT147 that 
we also found expressed. By quantitative PCR CT116, CT118 and CT147 
mRNAs were found to be expressed early in the C. trachomatis L2 
developmental cycle (Lutter et al. 2012). This indicates that the proteins are 
stable in the host cells. Therefore, the present proteomic study supports the 
results by Lutter et al. (2012) and Almeida et al. (2012) indicating that 
polymorphisms in the Inc genes are of importance for disease and tissue 
tropism. 
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